HSY vs LXRX · P/E 36, rev $5.89B vs rev $21.8M
Hershey Co (HSY) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Hershey Co (HSY) is a confectioners company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported HSY revenue for 2026-06-28 was $5.89B. Net income was $892.8M. Revenue was up 89.8% from 2026-03-29 to 2026-06-28. HSY currently screens at market cap $39.36B and trailing P/E 36.1.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
HSY currently screens at market cap $39.36B and trailing P/E 36.1. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the HSY and LXRX stock pages for the full models.
Not investment advice.